Education
About Us
Working with TipRanks
Follow Us
Daily Stock Ratings & Price Targets
Analyst Performance
Any
Analyst Rating
Any
Upside / Downside
Any
Action
Any
Market Cap
Any
Analyst & Firm | Company | Price | Rating & Price Target | Upside / Downside | Success Rate | Average Return | Action | Date | Article |
|---|---|---|---|---|---|---|---|---|---|
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $86→$92 | ― | 13.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $294→$290 | ― | 4.40% | Reiterated | ||||
 | Sun Communities | BUY $140 | ― | -0.30% | Reiterated | Strategic Leadership Transition at Sun Communities: Buy Rating Affirmed | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $108→$115 | ― | 4.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $21→$23 | ― | 8.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $280 | ― | 15.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $22 | ― | 13.40% | Reiterated | ||||
 | T Mobile US | BUY $272→$291 | ― | -1.60% | Reiterated | T-Mobile US: Strong Market Position and Growth Potential Justify Buy Rating | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $233→$188 | ― | 2.30% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $210→$230 | ― | 15.00% | Reiterated | ||||
 | Tesla | SELL $215 | ― | -9.10% | Reiterated | Tesla (TSLA) Gets a Sell from UBS | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $319 | ― | 5.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $300 | ― | 16.60% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $192 | ― | 13.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $112 | ― | 8.10% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $195→$220 | ― | 13.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $45→$65 | ― | 18.70% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $300 | ― | 11.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $210 | ― | 9.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $800 | ― | 4.80% | Upgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $305 | ― | 11.20% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $120 | ― | 18.80% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $41→$43 | ― | 10.10% | Downgraded | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $4.25→$3 | ― | 3.50% | Downgraded | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $270→$280 | ― | 5.00% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $60→$58 | ― | 6.30% | Reiterated | ||||
| Community Health | HOLD $4→$3.5 | ― | -8.40% | Reiterated | Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW) and Community Health (NYSE: CYH) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $200 | ― | 5.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $105 | ― | 3.50% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $296→$291 | ― | 11.30% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $37 | ― | 3.00% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $57→$58 | ― | 11.30% | Reiterated | ||||
 | Baker Hughes Company | BUY $48→$53 | ― | -1.10% | Reiterated | Barclays Keeps Their Buy Rating on Baker Hughes Company (BKR) | |||
| Weatherford International | BUY $77→$73 | ― | -1.10% | Reiterated | Weatherford International (WFRD) Receives a Buy from Barclays | |||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $253 | ― | 7.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $299→$298 | ― | 20.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $128→$136 | ― | 14.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $256→$273 | ― | 7.40% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $90 | ― | 4.90% | Reiterated | ||||
| Icon | HOLD $155 | ― | -9.60% | Reiterated | Barclays Sticks to Their Hold Rating for Icon (ICLR) | |||
| Molina Healthcare | HOLD $270 | ― | -8.40% | Reiterated | Barclays Sticks to Its Hold Rating for Molina Healthcare (MOH) | |||
| Tenet Healthcare | BUY $215→$208 | ― | -8.40% | Reiterated | Tenet Healthcare (THC) Gets a Buy from Barclays | |||
| Thermo Fisher | HOLD $450→$490 | ― | -9.60% | Reiterated | Barclays Keeps Their Hold Rating on Thermo Fisher (TMO) | |||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $36→$38 | ― | 4.70% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $580→$706 | ― | 11.20% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $520→$580 | ― | 10.80% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | SELL $92→$90 | ― | 11.20% | Reiterated | ||||
| xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | HOLD $45 | ― | 10.80% | Reiterated | ||||
 xxxxxxxxxxxxxxxxxx | xxxxxxxxxxxxxxxxxxxxxxxxxxx | BUY $69 | ― | 18.20% | Reiterated | ||||
 | Tesla | HOLD $275 | ― | -4.30% | Reiterated | Barclays Sticks to Their Hold Rating for Tesla (TSLA) |
Rows:
